Predictions Markets Are Pointing to a Potential Recession. 3 Stocks to Buy.

Polymarket assigns ~30% odds of a U.S. recession this year; the article flags three defensive stocks—Walmart, Netflix and Philip Morris—that historically outperform in recessions. Walmart (WMT) now gets ~60% of sales from groceries and showed strong recession performance (WMT +21% in 2020; +3%/+18% in 2007/2008; +8% in 2001), aided by low-cost positioning and Walmart+ convenience. Netflix (NFLX) posted +3%/+12%/+84% across 2007–2009 and +67% in 2020; ad-supported lower-priced tiers should help subscriber growth in a downturn, while Philip Morris (PM) is positioned defensively with addictive product demand and growth catalysts from smoke-free products (Zyn, Iqos) and potential FDA approvals (Zyn Ultra, Iluma).

Analysis

Winners will be companies that convert discretionary spend into recurring, necessity-like revenue and that can flex distribution economics quickly. Walmart’s scale in grocery and fulfillment gives it optionality to compress prices and expand private-label penetration, which will exert margin pressure on mid-sized grocers and food suppliers (expect 200–400bp pressure on regional peers’ grocery margins over 6–12 months). Netflix’s ad-SVOD pivot creates a high-leverage revenue lever: a 5–7% incremental ARPU lift from ads plus a 3–5% subs share gain in weakness can translate into outsized free-cash-flow improvements because content amortization is largely fixed in the near term.

Key tail risks are asymmetric and mostly binary. For Netflix, ad-monetization underperformance or material ARPU cannibalization could erase expected earnings upside within 2–4 quarters; for Philip Morris, FDA decisions (Iluma/IQOS/any Zyn classification) are 6–24 month binary catalysts that swing valuation multiples more than cyclical demand. Macroeconomically, a shallow, short (1–3 quarter) recession benefits defensive consumption shares; a long, deep recession (>4 quarters) increases credit stress and could compress trade credit terms for suppliers, amplifying inventory and receivables risk for large-cap retailers.

Given those dynamics, position sizing should express convexity to product-cycle catalysts and regulatory binaries rather than blunt market exposure. Use calibrated option structures to buy asymmetric upside (long-dated call spreads) while funding with short-term hedges; prefer pair trades that isolate product-mix or execution risk (retailer execution vs. subscription monetization vs. product approvals). Monitor three triggers: US recession data (NBER/2Q GDP), Netflix ad RPMs and churn (quarterly), and PM FDA milestone calendar.

Key Decisions for Investors

• Long WMT vs short TGT (pair): size 3–5% net exposure long WMT / 3–5% short TGT; horizon 6–12 months. Execution: buy WMT 9-month call spread (buy ATM, sell 20–25% OTM) funded by short TGT 3–6 month puts. R/R: asymmetric — target 15–30% gross return if Walmart gains share in groceries; downside ~10–12% if broad retail sell-off (limited by spread).
• Long NFLX stock or 18-month call LEAP: buy NFLX Jan-2028 $x/$y call spread (choose strikes ~20–25% apart) to express ad-tier monetization and subs upside; horizon 12–24 months. Hedge with a small WBD short (6–12 months) to isolate theatrical/cable risk. R/R: expect 20–40% upside if ad RPMs and ARPU improve; downside capped by premium paid on spread (~10–15%).
• Long PM vs short MO (pair): buy PM Jan-2028 LEAP calls or stock (target 4–6% allocation) and short MO equal notional to express relative product-cycle advantage. Timeframe 12–36 months tied to FDA approvals. R/R: 25–50% upside if smoke-free conversion accelerates and pricing holds; binary regulatory risk could cause >20% drawdown — size accordingly and use 12–18% protective put coverage around major FDA decision windows.
• Tactical hedge: buy 3–6 month S&P put protection (or inverse beta via VIX calls) sized to limit portfolio drawdowns to target volatility if recession probability moves above 40% in next 60 days. Purpose: protects option-funded trades from idiosyncratic macro shocks with limited carry.